Stem Cells Market Size [2021-2028] Exhibits 12.8% CAGR to Reach USD 27.65 Billion by 2028
November 22, 2022 04:05 ET
|
Fortune Business Insights
Pune, India, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Fortune Business Insights has published latest forecast for stem cells market in their report titled, “Stem Cells Market Forecast, 2021-2028”. As per...
Congress Introduced with “Access to Future Cures Act” Aimed at Enabling Precision Medicine for Future Cellular & Gene Therapies
September 26, 2022 07:30 ET
|
GoodCell
Norwalk, CT, Sept. 26, 2022 (GLOBE NEWSWIRE) -- H.R.8912, the “Access to Future Cures Act,” was introduced to Congress on September 20th which aims to expand Health Savings Account (HSA), Health...
Mesenchymal stem cells market is projected to grow at a CAGR of 13.82% by 2032: Visiongain Research Inc
September 26, 2022 05:15 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Mesenchymal Stem Cells Market 2022-2032. It includes profiles of Mesenchymal Stem Cells Market and Forecasts Market Segment by Type {Product (Cell &...
Merakris Sponsored Study Opens Door to Precision-Based Approaches to Wound Healing
September 13, 2022 06:00 ET
|
Merakris Therapeutics
RESEARCH TRIANGLE PARK, N.C., Sept. 13, 2022 (GLOBE NEWSWIRE) -- A recently published manuscript containing research sponsored, in part, by Merakris Therapeutics has opened the door to more...
L’étude sur le TH1902 de Theratechnologies publiée dans la revue Pharmaceutics montre une inhibition de la croissance des cellules de type souches cancéreuses humaines du cancer de l’ovaire et du CSTN exprimant le récepteur de la sortiline (SORT1) et de la croissance tumorale
September 12, 2022 07:30 ET
|
Theratechnologies
Les chercheurs signalent une activité anticancéreuse supérieure contre les cellules de type souches cancéreuses avec le TH1902, comparativement au docétaxel non conjugué.Premières données probantes...
Theratechnologies TH1902 Study Published in Pharmaceutics Demonstrates Inhibition of Human Sortilin (SORT1)-Positive Ovarian and Triple-Negative Breast Cancer Stem-Like Cells and Tumor Growth
September 12, 2022 07:30 ET
|
Theratechnologies
Researchers report superior anticancer activity against cancer stem-like cells with TH1902, compared to unconjugated docetaxelFirst evidence for TH1902 targeting of human breast and ovarian cancer...
New Study Finds Mouse Embryonic Stem Cells Have No Special Requirement for Threonine
September 07, 2022 10:00 ET
|
Experimental Biology and Medicine
WASHINGTON, Sept. 07, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 15, August, 2022) challenges that mouse embryonic stem cells are...
Global Cell Cryopreservation Market to Surpass US$ 43,546.4 Million by 2030, Says Coherent Market Insights (CMI)
August 18, 2022 09:10 ET
|
CMI
Seattle, Aug. 18, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global cell cryopreservation market is estimated to be valued at US$ 8,659.4 million in 2022 and is expected to...
With 12.8% CAGR, Stem Cells Market Size worth USD 27.65 Billion in 2028
July 06, 2022 08:29 ET
|
Fortune Business Insights
Pune, India, July 06, 2022 (GLOBE NEWSWIRE) -- The global stem cells market size is expected to gain momentum by reaching USD 27.65 billion by 2028. Fortune Business Insights in its latest report,...
GoodCell Offers Personal Biobanking Early Adopter Discount for a Limited Time
June 13, 2022 07:00 ET
|
GoodCell
Waltham, MA, June 13, 2022 (GLOBE NEWSWIRE) -- Today, GoodCell, a life sciences company, is announcing a limited-time early adopter discount for Personal Biobanking, a proactive, preventative...